Fellows Class of 2019–2021

Two fellowships were offered and accepted for the class that started July 1, 2019.

Daniel H. Taupin, MD

Dr. Taupin is currently an Infectious Disease Fellow at Beth Israel Deaconess Medical Center. He is leading a project within the House Staff Quality Improvement Council to reduce medication dosing errors and a project to improve Outpatient Parenteral Antimicrobial Therapy (OPAT) outcomes. He completed medical school at New York University School of Medicine and remained at NYU for internal medicine residency as well as a year of Chief Residency from July 2017 to June 2018.

During residency he led a multidisciplinary team to create an HCV care coordination algorithm and an HCV educational campaign targeting internal medicine. In another project he worked closely with pharmacy leadership to mandate dedicated time for interns and clinical pharmacotherapy specialists to collaboratively review all pending discharge medication reconciliations. He also collaborated with hospital leadership to create a novel internal medicine resident team structure and call schedule that led to the elimination of cross coverage and the use of bedside handoffs.

Dr. Taupin plans to pursue a career in infectious disease where well-established programs such as infection control and antimicrobial stewardship combine with emerging initiatives allowing him to integrate his QI and ID expertise. He is particularly interested in improving the quality of care for our population of people who inject drugs (PWID), a group in desperate need of targeted healthcare interventions.

Jonathan P. Zebrowski, MD

Dr. Zebrowski is currently the Chief Resident of outpatient psychiatry at Massachusetts General Hospital and a Resident in adult psychiatry at Massachusetts General Hospital - McLean Hospital. He received his medical degree from Emory University and is completing his residency at Massachusetts General Hospital - McLean Hospital.

During his residency he co-founded the MGH/McLean Psychiatry Resident Quality & Safety Committee, which convenes a group of residents interested in tackling meaningful quality improvement projects within the residency program. As chief resident of outpatient psychiatry, he is working with program leadership to develop mechanisms to identify, capture, and report EMR-based quality and outcome measures within the resident clinic so that residents receive meaningful, actionable data on their practice per ACGME mandate.

Dr. Zebrowski hopes to use his interest in systems and structural change to become a quality and safety leader in the practice of Psychiatry and contribute to the community of change locally and nationally.

His interests include tracking prescribing of deliriogenic medications in geriatric populations, increasing access to buprenorphine treatment for opioid use disorder, tracking co-prescription of multiple controlled substances, and improving communication between psychiatrists and other members of treatment teams.